Afrezza+Tresiba+Russia

Day 31 – Afrezza and Tresiba Post Russia

Here I am, 31 days after leaving for Russia, back in the States for the 4th day. I have many questions, because my use of Afrezza and Tresiba have gone up considerably. Reduced Tresiba in Russia My questions come partly from my earlier post, where I noted that I had reduced my basal insulin usage considerably upon arriving in Russia. When […]

Read more
Afrezza+Tresiba+Russia

Day 13 – Afrezza and Tresiba in Russia

I had a hard time picking the subject of this post. It came down to Afrezza and Tresiba in Russia as they were an easy subject for me. Afrezza and Tresiba an Easy Subject Why are Afrezza and Tresiba as easy subject?  It is because life has been simple while in Russia, using these two drugs. I have been able to live a fairly […]

Read more
Continuous Glucose Monitor (CGM) Graph

Additional Notes: Dexcom vs Medtronic CGM

I have some more thoughts on my earlier Dexcom and Medtronic continuous glucose monitor comparison (CGM) that I did not mention yesterday. CGM Notifications The Medtronic 530G can send notifications from the Minimed Connect CGM application to you via text message. They are fairly useless alerts. They simply say “High SG, CHECK BG.” For a text message notification to be useful, I […]

Read more
Continuous Glucose Monitor (CGM) Graph

Continuous Glucose Monitor: Dexcom vs Medtronic

I have used the Medtronic 530G insulin pump with Enlite CGM sensors for 3 years. I recently tried the Dexcom G4 Platinum continuous glucose monitor for a week. There are things I like about both, and things I dislike about both continuous glucose monitors. I will not get into technical differences, just observations. Full disclosure: I have used an insulin pump since […]

Read more

Afrezza – One Diabetics Rocky Road to Better Control

In my last post, I talked about what Afrezza is, my Type 1 diabetes background, and what Afrezza has done for me in a very short time. My trip to using Afrezza was a rocky road, however. I had done plenty of research on inhaled insulin, other’s experience with Afrezza (and Tresiba, which I now use for my basal insulin, […]

Read more

Afrezza – a Trip to a Healthier Diabetic

What is Afrezza? In short, it is an inhaled insulin created by MannKind Corporation, based on Technosphere technology, and until recently, marketed and distributed by Sanofi. If you want the short story and some rumors surrounding the breakup of Sanofi and MannKind, The Motley Fool has some tidbits you can read. What I will say about Afrezza, is it has greatly […]

Read more
1 2 3 4